Literature DB >> 29663478

Superb Microvascular Imaging of the Median Nerve in Carpal Tunnel Syndrome: An Electrodiagnostic and Ultrasonographic Study.

Ali Yavuz Karahan1, Serdar Arslan2, Banu Ordahan3, Suleyman Bakdik2, Timur Ekiz4.   

Abstract

OBJECTIVE: To evaluate intraneural blood flow of the median nerve using superb microvascular imaging (SMI) and power Doppler ultrasonography (PDUS), and to examine their correlation with electroneuromyography in patients with carpal tunnel syndrome (CTS).
METHODS: A cross-sectional survey was used, and the study was conducted in the research unit of a training and research hospital. Patients diagnosed with CTS according to electroneuromyography studies were included in the study. Ultrasound measurements were taken using an Aplio-500 (Toshiba Medical System Corporation, Tokyo, Japan) device and a linear multifrequency 14-MHz probe. The cross-sectional area of the median nerve at the carpal tunnel level was measured by the direct tracing method using electronic calipers. The power Doppler ultrasonography and superb microvascular imaging scores were recorded by grading the vascularity between 0 and 3.
RESULTS: Evaluation was made of a total of 113 hands of 80 patients (18 men, 62 women) with a mean age of 34.67 ± 12.82 years. The mean duration of symptoms was 12.34 ± 6.66 months. When the patients were grouped as mild, moderate, and severe CTS, there was a statistically significant difference between the SMI and PDUS grades (P < .05). As the severity of CTS increased, an increase in SMI and PDUS scores was observed. There was a strong correlation between SMI scores and motor distal latency (r = .71/P = .026), amplitude of sensory action potential (r = -.77/P = .029), and sensory neurotransmission rate (r = .77/P = .029).
CONCLUSION: SMI seems to be more sensitive than PDUS for evaluating the vascularity of the median nerve in patients with CTS, and SMI grading is correlated with the ENMG results.
© 2018 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  entrapment neuropathy; musculoskeletal ultrasound; peripheral nerve; superb microvascular imaging; ultrasonography

Mesh:

Year:  2018        PMID: 29663478     DOI: 10.1002/jum.14645

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  5 in total

1.  Carpal tunnel ultrasound: is the "safe zone" on the ulnar side of the median nerve really avascular?

Authors:  Anne-Charlotte Sergeant; Sammy Badr; Marc Saab; Xavier Demondion; Anne Cotten; Thibaut Jacques
Journal:  Eur Radiol       Date:  2019-08-29       Impact factor: 5.315

2.  Combination of high-frequency ultrasound and virtual touch tissue imaging and quantification improve the diagnostic efficiency for mild carpal tunnel syndrome.

Authors:  Zhen-Han Lai; Shu-Ping Yang; Hao-Lin Shen; Yi Luo; Xiao-Han Cai; Wen-Ting Jiang; Li-Ping Liao; Kun-Bin Wu; Guo-Rong Lv
Journal:  BMC Musculoskelet Disord       Date:  2021-01-26       Impact factor: 2.362

3.  Superb microvascular imaging for detecting carpal tunnel syndrome compared with power Doppler ultrasonography: A protocol for systematic review and meta-analysis.

Authors:  Jili Zhang; Weikai Zhu; Mingxin Lin; Chang Jiang
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

4.  The value of sonographic quantitative parameters in the diagnosis of carpal tunnel syndrome in the Vietnamese population.

Authors:  Nhu Quynh Vo; Thi Hieu Dung Nguyen; Duy Duan Nguyen; Trong Binh Le; Nghi Thanh Nhan Le; Thanh Thao Nguyen
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

5.  Diagnostic Utility of Superb Microvascular Imaging and Power Doppler Ultrasonography for Visualizing Enriched Microvascular Flow in Patients With Carpal Tunnel Syndrome.

Authors:  Takeshi Endo; Yuichiro Matsui; Daisuke Kawamura; Atsushi Urita; Daisuke Momma; Mitsutoshi Ota; Hiroki Shibayama; Takahito Iwai; Mutsumi Nishida; Norimasa Iwasaki
Journal:  Front Neurol       Date:  2022-03-31       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.